Top 10 Warren Buffett Stocks To Invest In Right Now

tags:ATU,BOFI,XENE,BRKL,HPQ,STN,RXII,LIVE,SBGL,AGEN,

When Warren Buffett announced in 2006 that he would gradually�give away the majority of his fortune to charity,�he wasn��t kidding.

The billionaire investor just donated another 18.6 million Class B shares of Berkshire Hathaway worth $3.17 billion to five different foundations. That puts his total charitable contribution to the organizations at $27.54 billion in just over ten years.

The five foundations receiving this donation include the�Bill & Melinda Gates Foundation, Susan Thompson Buffett Foundation, Sherwood Foundation, Howard G. Buffett Foundation and NoVo Foundation.

The CEO of Berkshire Hathaway is worth more than $70 billion and is ranked as the world��s second richest person, just behind Bill Gates, according to Forbes magazine. �

Buffett has made a pledge to make annual gifts of stock to the foundations throughout his lifetime and beyond.

Top 10 Warren Buffett Stocks To Invest In Right Now: Actuant Corporation(ATU)

Advisors' Opinion:

• [By Ethan Ryder]

  Eaton (NYSE: ETN) and Actuant (NYSE:ATU) are both industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Actuant (ATU)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Invest In Right Now: BofI Holding Inc.(BOFI)

Advisors' Opinion:

• [By Jordan Wathen, Dan Caplinger, and Sean Williams]

  Below, three Fool.com investors make the case for adding shares of Fifth Third Bancorp (NASDAQ:FITB), BofI Holding�(NASDAQ:BOFI), and Deutsche Bank (NYSE:DB) to your portfolio.

• [By Jason Hall]

  BofI Holding Inc�(NASDAQ:BOFI) has made for a remarkable investment over the past decade. Its stock price is up an incredible 2,140% since the start of 2008, a remarkable�17-fold�better total return than the�S&P 500�over the same period of time. Over that period it has grown its assets almost 860% and increased earnings per share almost 2,600%.�

• [By Jason Hall]

  Internet-only bank�BofI Holding, Inc.�(NASDAQ:BOFI) reported its third-quarter fiscal 2018 earnings after market close on April 26, delivering a solid 27% increase in earnings per share. Book value per share increased 16.5% in the quarter, spurred higher by 15% growth of its loan portfolio. Deposits also grew an impressive total, up 17% in the quarter, providing BofI with the necessary cash to fund its loan growth.�

• [By Dan Caplinger]

  The relationship between people and banks has changed dramatically over the past 20 years. Previous generations had strong personal relationships with bankers at physical branch locations in their areas, and over time, Bank of America (NYSE:BAC) has gobbled up countless smaller institutions to become the national behemoth it is today. Younger customers have gravitated toward internet banking, and BofI Holding (NASDAQ:BOFI) and its Bank of Internet USA have captured a good deal of the resulting business from those who value better rates above in-person customer service.

Top 10 Warren Buffett Stocks To Invest In Right Now: Xenon Pharmaceuticals Inc.(XENE)

Advisors' Opinion:

• [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss. Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results. Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88. Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results. SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results. Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat. Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results. LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results. ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results. Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. MYnd
• [By Lisa Levin] Gainers Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results. Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018. HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat. Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday. Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile. Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results. Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva. China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter. PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
• [By Chris Lange]

  Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials. Specifically, Xenon presented data from its XEN901 Phase 1 clinical trial and from its XEN1101 Phase 1 clinical trial at the Eilat Conference on New Antiepileptic Drugs and Devices in Madrid, Spain.

Top 10 Warren Buffett Stocks To Invest In Right Now: Brookline Bancorp Inc.(BRKL)

Advisors' Opinion:

• [By Stephan Byrd]

  Brookline Bancorp, Inc. (NASDAQ:BRKL) – Equities research analysts at Piper Jaffray upped their Q3 2018 EPS estimates for shares of Brookline Bancorp in a research report issued on Thursday, May 3rd. Piper Jaffray analyst M. Breese now anticipates that the bank will post earnings of $0.28 per share for the quarter, up from their prior estimate of $0.27. Piper Jaffray has a “Hold” rating and a $16.50 price objective on the stock. Piper Jaffray also issued estimates for Brookline Bancorp’s Q4 2018 earnings at $0.29 EPS, FY2018 earnings at $1.08 EPS, Q1 2019 earnings at $0.29 EPS, Q3 2019 earnings at $0.30 EPS and FY2019 earnings at $1.18 EPS.

• [By Joseph Griffin]

  Brookline Bancorp (NASDAQ: BRKL) and People's United Financial (NASDAQ:PBCT) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Top 10 Warren Buffett Stocks To Invest In Right Now: HP Inc.(HPQ)

Advisors' Opinion:

• [By Chris Lange]

  HP Inc. (NYSE: HPQ) and Hewlett Packard Enterprise Co. (NYSE: HPE) reported their most recent quarterly results after the markets closed on Thursday. Each report was fairly positive, and these split companies both appear to be on the right track.

• [By Paul Ausick]

  Fourth-quarter 2017 shipments of personal computers (PCs), including desktops and laptops, fell 2% year over year to an estimated 71.56 million units. HP Inc. (NYSE: HPQ) was the volume and market-share leader with worldwide shipments totaling 16.08 million in the quarter and a share of 22.5%. For the full year, worldwide shipments dipped 2.8% to 262.54 million units.

• [By Chris Lange]

  HP Inc. (NYSE: HPQ) is set to report its most recent quarterly results on Tuesday. Analysts are looking for $0.48 in earnings per share (EPS) and $13.57 billion in revenue. Shares closed the week at $21.91, with a consensus price target of $25.76 and a 52-week trading range of $17.10 to $24.75.

• [By ]

  Also, the installation of Visentin hints that Icahn's ultimate goal may be to drive the document processing company to sell itself to HP Inc. (HPQ) for a premium rather than merge with Fujifilm. TheStreet's sister publication, The Deal, had learned last month that HP was a possible bidder for Xerox before the Fuji deal had been struck. Another alternative is for Fujifilm to increase its offer to Xerox shareholders, though it is unclear whether a higher bid would be enough to appease Icahn.

• [By Tyler Crowe, Leo Sun, and Brian Feroldi]

  So, we asked three of our investing contributors to highlight stocks that would be well suited for a baby boomer's portfolio. Here's a brief rundown as to why they picked HP (NYSE:HPQ), ResMed (NYSE:RMD), and American Tower (NYSE:AMT).�

Top 10 Warren Buffett Stocks To Invest In Right Now: Stantec Inc(STN)

Advisors' Opinion:

• [By Lisa Levin] Companies Reporting Before The Bell Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million. AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million. Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion. Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion. Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion. Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion. Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million. Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million. ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million. Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion. Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion. Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion. NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million. World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million. MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million. Choice Hotels International, Inc. (NYSE: CH
• [By Shane Hupp]

  Get a free copy of the Zacks research report on Stantec (STN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Stantec (TSE:STN) (NYSE:STN) has received a consensus rating of “Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is C$36.50.

Top 10 Warren Buffett Stocks To Invest In Right Now: RXI Pharmaceuticals Corporation(RXII)

Advisors' Opinion:

• [By Lisa Levin] Gainers MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast. The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results. Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome. RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics. ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings. ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results. Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings. Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

  Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

• [By Lisa Levin] Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share. Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook. vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June. Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results. RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million. Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter. Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales. Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings. MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma. New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor. Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session. Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Top 10 Warren Buffett Stocks To Invest In Right Now: Live Ventures Incorporated(LIVE)

Advisors' Opinion:

• [By Ethan Ryder]

  Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Top 10 Warren Buffett Stocks To Invest In Right Now: Sibanye Gold Limited(SBGL)

Advisors' Opinion:

• [By Lisa Levin]

   

  Losers Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results. Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results. SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss. Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday. Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million. Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday. ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today. ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79. Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss. Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss. iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results. Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97. Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15. AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings. Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49. Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday. Myomo, Inc. (NYSE: MYO) slipp
• [By Joseph Griffin]

  TRADEMARK VIOLATION WARNING: “Sibanye Gold Ltd (SBGL) Receives Average Recommendation of “Buy” from Analysts” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3364474/sibanye-gold-ltd-sbgl-receives-average-recommendation-of-buy-from-analysts.html.

• [By Logan Wallace]

  Shares of Sibanye Gold Ltd (NYSE:SBGL) have been assigned a consensus rating of “Buy” from the seven brokerages that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company.

• [By Paul Ausick]

  Sibanye Gold Ltd. (NYSE: SBGL) traded down about 1.6% Thursday and posted a new 52-week low of $3.75 after closing Wednesday at $3.81. The stock’s 52-week high is $10.60. Volume totaled around 3 million, about 15% below the daily average. The company had no specific news. Another stock that has turned it around today and looks to close about 1% higher.

• [By Paul Ausick]

  Sibanye Gold Ltd. (NYSE: SBGL) traded down about 8.4% Monday to post a new 52-week low of $3.16 after closing Friday at $3.45. The stock’s 52-week high is $8.66. Volume was about 35% above the daily average of around 3.9 million shares. The company had no specific news.

Top 10 Warren Buffett Stocks To Invest In Right Now: Agenus Inc.(AGEN)

Advisors' Opinion:

• [By Max Byerly]

  Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

• [By Cory Renauer]

  Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

• [By Shane Hupp]

  Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

• [By Cory Renauer]

  Attention bargain shoppers: There could be some deals in aisle biotech.�Agenus Inc.�(NASDAQ:AGEN)�and�Regeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market's reaction to recent events seems a bit overdone.��